What are you looking for?

Seagen | Branding Case Study | Stark Raving Boston

Seagen Logo

Building Global Clinical Trial Success for Breakthrough Immunotherapy Combinations

Seagen Logo

THE CHALLENGE
Non-small cell lung cancer and melanoma patients were running out of treatment options, but Seagen had developed SEA-CD40, a revolutionary immunotherapy that could potentially supercharge the body’s own immune system to fight these aggressive cancers. However, they faced a massive global recruitment challenge: how do you reach desperate cancer patients across seven countries and ten languages while managing the complexity of five different treatment cohorts with specific eligibility requirements? The stakes couldn’t be higher—patients needed access to breakthrough treatments, but complex international trials often struggle to enroll enough participants to prove effectiveness.

 

THE SOLUTION
We created a comprehensive global recruitment strategy that transformed Seagen’s complex multi-cohort trial into clear pathways of hope for cancer patients worldwide. Rather than overwhelming patients with technical details about immunotherapy combinations, we focused on what mattered most: the possibility of accessing cutting-edge treatment that could extend their lives when other options had failed. Our culturally sensitive materials spoke to patients in their native languages while helping them understand which cohort offered the best chance for their specific situation. The result: a recruitment campaign that not only filled the challenging SGNS40-002 study but also established a new standard for inclusive global cancer research that truly serves the diverse populations fighting these devastating diseases.

KEY OUTCOMES

  • Saved 4% of their total SaaS spend in the first 3 months, and 16% in the first year working with Zylo
  • Revealed 30% overspend in budget
  • Saved 10 hours per week, allowing more focus on strategic work
  • 75 contracts negotiated by Zylo in year one
  • Reduced number of applications by 10% while experiencing rapid growth
Non-small cell lung cancer clinical study patient recruitment branding services
Non-small cell lung cancer clinical study patient recruitment branding services

Developing a strong brand identity for a competitive therapeutic area.

The field of oncology clinical trials is highly competitive, requiring a strong brand presence to differentiate from other studies. To achieve this, our creative team utilized Seagen’s brand guidelines for the compound and developed a unique brand identity that effectively conveyed the study opportunity and established credibility and trust. By integrating patient-friendly language with a dynamic and forward-thinking design, we engaged potential study participants and encourage enrollment.

Non-small cell lung cancer clinical study patient recruitment branding services
Non-small cell lung cancer clinical study patient recruitment content and branding services
Non-small cell lung cancer clinical study patient recruitment branding services

A study toolkit that equally supports patients, caregivers, and site staff.

Enabling patients to make informed decisions is just as crucial as equipping site staff with the necessary resources to educate patients about the study opportunity. To achieve this for the clinical trial, our creative team crafted a variety of educational and instructional tools that targeted both patients and site staff. These tools served to keep the trial at the forefront of their minds and ensure adherence to the protocol’s requirements.

Non-small cell lung cancer clinical study patient recruitment paid social services

Enhancing patient recruitment with site-based promotional tools.

Our social media team created a set of IRB-approved promotional materials to help the study site enhance its database of potential study participants. These materials were designed to increase site-based patient recruitment efforts. In addition, we developed promotional content tailored specifically to advocacy groups and referring physicians designed to expand the site’s reach and network of potential participants.

Non-small cell lung cancer clinical study patient recruitment paid social services

Fast-tracking production and distribution to meet study timelines.

Our translation, printing, and distribution process is tailored to the specific requirements of clinical research. We have optimized our methods to ensure that all materials are prepared and ready for production immediately after receiving IRB or EC approvals. This streamlined approach facilitates the swift deployment of study toolkits.

Non-small cell lung cancer clinical study patient recruitment marketing timeline organization
Non-small cell lung cancer clinical study patient recruitment translation and production services

Expanding the campaign to seven countries and ten languages.

This clinical trial had a global presence in seven countries and involved 10 languages. To expand the patient-facing campaign into five European countries and Canada, we collaborated with a team of professional in-country translators. In addition to translating and formatting the study materials, our design team ensured that all imagery was culturally appropriate for each participating country.

Non-small cell lung cancer clinical study patient recruitment translation and production services
Non-small cell lung cancer clinical study patient recruitment branding services

On-demand printing and distribution that aligned with EC approvals.

Due to rolling Ethics Committee approvals and staggered country and site activations, we had to adopt an agile approach to produce and distribute the study materials for patients and sites. To meet the demand, our team utilized on-demand printing in the United States and Europe. Within an average of 10 business days after receiving EC approvals, study sites received their materials.

Non-small cell lung cancer clinical study patient recruitment branding services

Ready to transform your business?
Let's get started today.

Contact Us
Back Top